Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,207 public trials 1,884 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Terminated

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

NCT06039384

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Banner Md Anderson Cancer Center Greeley, Colorado, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Mary Crowley Cancer Research Centers McCrc Headquarters Dallas, Texas, United States
View all 14 locations
View Trial Details
Terminated

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

NCT05275868

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Wash U School of Medicine St Louis, Missouri, United States
  • NYU School of Medicine New York, United States
View all 15 locations
View Trial Details
Terminated

A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)

NCT06333678

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • University of Michigan (Data Collection Only) Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

NCT05827614

Conditions
Anogenital Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Santa Monica, California, United States
  • HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 16 locations
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details

Related conditions